The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

2014 & 2015 IPOs

April 22, 2016

Buy ($175)

Companies covered: EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), People's Utah Bancorp (NASDAQ:PUB), Second Sight Medical Products, Inc. (NASDAQ:EYES), Ocular Therapeutix, Inc. (NASDAQ:OCUL), Tobira Therapeutics Inc. (NASDAQ:TBRA), Pfenex Inc. (AMEX:PFNX), Connecture, Inc. (NASDAQ:CNXR), Immune Design Corp. (NASDAQ:IMDZ), Tuniu Corporation (NASDAQ:TOUR), Milacron Holdings Corp. (NYSE:MCRN)

Interview with the President and CEO: EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG)
Stephen From
Interview with the CEO and the CFO: CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD)
Thomas P. Mathers;  Matthew Dallas
Interview with the CEO and President: People's Utah Bancorp (NASDAQ:PUB)
Richard T. Beard
Interview with the President and CEO: Second Sight Medical Products Inc. (NASDAQ:EYES)
Will McGuire
Interview with the President, CEO and Chairman: Ocular Therapeutix Inc. (NASDAQ:OCUL)
Amarpreet Sawhney
Interview with the CEO: Tobira Therapeutics Inc. (NASDAQ:TBRA)
Laurent Fischer
Interview with the CFO: Pfenex Inc. (NYSEMKT:PFNX)
Paul A. Wagner
Interview with the CEO: Connecture Inc. (NASDAQ:CNXR)
Jeff Surges
Interview with the President, CEO and Director: Immune Design Corp. (NASDAQ:IMDZ)
Carlos Paya
Interview with the CFO: Tuniu Corporation (NASDAQ:TOUR)
Conor Chia-hung Yang
Interview with the President and CEO and the CFO: Milacron Holdings Corp. (NYSE:MCRN)
Tom Goeke;  Bruce Chalmers
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy